We are analyzing https://link.springer.com/article/10.1007/s11154-013-9260-x.

Title:
Role of oxytocin signaling in the regulation of body weight | Reviews in Endocrine and Metabolic Disorders
Description:
Obesity and its associated metabolic disorders are growing health concerns in the US and worldwide. In the US alone, more than two-thirds of the adult population is classified as either overweight or obese [1], highlighting the need to develop new, effective treatments for these conditions. Whereas the hormone oxytocin is well known for its peripheral effects on uterine contraction during parturition and milk ejection during lactation, release of oxytocin from somatodendrites and axonal terminals within the central nervous system (CNS) is implicated in both the formation of prosocial behaviors and in the control of energy balance. Recent findings demonstrate that chronic administration of oxytocin reduces food intake and body weight in diet-induced obese (DIO) and genetically obese rodents with impaired or defective leptin signaling. Importantly, chronic systemic administration of oxytocin out to 6 weeks recapitulates the effects of central administration on body weight loss in DIO rodents at doses that do not result in the development of tolerance. Furthermore, these effects are coupled with induction of Fos (a marker of neuronal activation) in hindbrain areas (e.g. dorsal vagal complex (DVC)) linked to the control of meal size and forebrain areas (e.g. hypothalamus, amygdala) linked to the regulation of food intake and body weight. This review assesses the potential central and peripheral targets by which oxytocin may inhibit body weight gain, its regulation by anorexigenic and orexigenic signals, and its potential use as a therapy that can circumvent leptin resistance and reverse the behavioral and metabolic abnormalities associated with DIO and genetically obese models.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Non-Profit & Charity
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

research, support, google, scholar, pubmed, cas, govt, oxytocin, nonus, nih, extramural, physiol, neurons, nucleus, phs, rats, intake, neurosci, obesity, brain, food, review, receptor, rat, effects, leptin, hypothalamic, peptide, central, endocrinology, comp, study, mice, res, weight, hypothalamus, paraventricular, expression, nonphs, gastric, regul, signaling, doijneurosci, body, blevins, control, hindbrain, comparative, feeding, doien,

Topics {✒️}

tnf-alpha-induced c-fos generation corticotropin-releasing hormone-synthesizing neurons meal-induced c-fos expression month download article/chapter fat-rich diet activates methamphetamine-induced hyperactivity related severe early-onset obesity prolactin-releasing peptide receptor leptin-regulated genes revealed hetero-dimeric complex formations diet-induced obese mice hypothalamic-pituitary-adipose axis diet-induced obese rodents pro-opiomelanocortin gene transfer refeeding-activated glutamatergic neurons pvn-hindbrain pathway involved nicotine-induced cfos expression resting-stage feeding manipulation diet-induced obese rats gut-sensitive feeding processes llewellyn-smith ij leptin-independent melanocortin pathway retrograde tract-tracing studies pvn-hindbrain feeding pathway lesioning oxytocin-receptive neurons region-specific leptin resistance nesfatin-1-regulated oxytocinergic signaling ventral tegmental area high-fat diet c-fos expression diet-induced obese brainstem nutrient sensing putative satiety cells hypothalamic hyperphagia-obesity syndrome pgc-1alpha deficiency prolactin releasing peptide prolactin-releasing peptide centrally administered oxytocin express cck-induced activation diet-induced obesity high energy diets cholecystokinin-induced satiety anorectic peptide regulated cholecystokinin-mediated suppression oxytocin decreases methamphetamine visceral fat mass long-term impairments privacy choices/manage cookies cholecystokinin-induced suppression activates hindbrain glucagon

Questions {❓}

Hypothesis paper Brain talks with fat–evidence for a hypothalamic-pituitary-adipose axis?
The brain oxytocin receptor(s)?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Role of oxytocin signaling in the regulation of body weight
         description:Obesity and its associated metabolic disorders are growing health concerns in the US and worldwide. In the US alone, more than two-thirds of the adult population is classified as either overweight or obese [1], highlighting the need to develop new, effective treatments for these conditions. Whereas the hormone oxytocin is well known for its peripheral effects on uterine contraction during parturition and milk ejection during lactation, release of oxytocin from somatodendrites and axonal terminals within the central nervous system (CNS) is implicated in both the formation of prosocial behaviors and in the control of energy balance. Recent findings demonstrate that chronic administration of oxytocin reduces food intake and body weight in diet-induced obese (DIO) and genetically obese rodents with impaired or defective leptin signaling. Importantly, chronic systemic administration of oxytocin out to 6 weeks recapitulates the effects of central administration on body weight loss in DIO rodents at doses that do not result in the development of tolerance. Furthermore, these effects are coupled with induction of Fos (a marker of neuronal activation) in hindbrain areas (e.g. dorsal vagal complex (DVC)) linked to the control of meal size and forebrain areas (e.g. hypothalamus, amygdala) linked to the regulation of food intake and body weight. This review assesses the potential central and peripheral targets by which oxytocin may inhibit body weight gain, its regulation by anorexigenic and orexigenic signals, and its potential use as a therapy that can circumvent leptin resistance and reverse the behavioral and metabolic abnormalities associated with DIO and genetically obese models.
         datePublished:2013-09-25T00:00:00Z
         dateModified:2013-09-25T00:00:00Z
         pageStart:311
         pageEnd:329
         sameAs:https://doi.org/10.1007/s11154-013-9260-x
         keywords:
            Satiety
            Meal size
            Oxytocin
            Hindbrain
            Endocrinology
            Diabetes
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11154-013-9260-x/MediaObjects/11154_2013_9260_Fig1_HTML.gif
         isPartOf:
            name:Reviews in Endocrine and Metabolic Disorders
            issn:
               1573-2606
               1389-9155
            volumeNumber:14
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:James E. Blevins
               affiliation:
                     name:Department of Veterans Affairs Medical Center
                     address:
                        name:VA Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Washington School of Medicine
                     address:
                        name:Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Jacqueline M. Ho
               affiliation:
                     name:Department of Veterans Affairs Medical Center
                     address:
                        name:VA Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Washington School of Medicine
                     address:
                        name:Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Role of oxytocin signaling in the regulation of body weight
      description:Obesity and its associated metabolic disorders are growing health concerns in the US and worldwide. In the US alone, more than two-thirds of the adult population is classified as either overweight or obese [1], highlighting the need to develop new, effective treatments for these conditions. Whereas the hormone oxytocin is well known for its peripheral effects on uterine contraction during parturition and milk ejection during lactation, release of oxytocin from somatodendrites and axonal terminals within the central nervous system (CNS) is implicated in both the formation of prosocial behaviors and in the control of energy balance. Recent findings demonstrate that chronic administration of oxytocin reduces food intake and body weight in diet-induced obese (DIO) and genetically obese rodents with impaired or defective leptin signaling. Importantly, chronic systemic administration of oxytocin out to 6 weeks recapitulates the effects of central administration on body weight loss in DIO rodents at doses that do not result in the development of tolerance. Furthermore, these effects are coupled with induction of Fos (a marker of neuronal activation) in hindbrain areas (e.g. dorsal vagal complex (DVC)) linked to the control of meal size and forebrain areas (e.g. hypothalamus, amygdala) linked to the regulation of food intake and body weight. This review assesses the potential central and peripheral targets by which oxytocin may inhibit body weight gain, its regulation by anorexigenic and orexigenic signals, and its potential use as a therapy that can circumvent leptin resistance and reverse the behavioral and metabolic abnormalities associated with DIO and genetically obese models.
      datePublished:2013-09-25T00:00:00Z
      dateModified:2013-09-25T00:00:00Z
      pageStart:311
      pageEnd:329
      sameAs:https://doi.org/10.1007/s11154-013-9260-x
      keywords:
         Satiety
         Meal size
         Oxytocin
         Hindbrain
         Endocrinology
         Diabetes
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11154-013-9260-x/MediaObjects/11154_2013_9260_Fig1_HTML.gif
      isPartOf:
         name:Reviews in Endocrine and Metabolic Disorders
         issn:
            1573-2606
            1389-9155
         volumeNumber:14
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:James E. Blevins
            affiliation:
                  name:Department of Veterans Affairs Medical Center
                  address:
                     name:VA Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Washington School of Medicine
                  address:
                     name:Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Jacqueline M. Ho
            affiliation:
                  name:Department of Veterans Affairs Medical Center
                  address:
                     name:VA Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Washington School of Medicine
                  address:
                     name:Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Reviews in Endocrine and Metabolic Disorders
      issn:
         1573-2606
         1389-9155
      volumeNumber:14
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Department of Veterans Affairs Medical Center
      address:
         name:VA Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, USA
         type:PostalAddress
      name:University of Washington School of Medicine
      address:
         name:Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, USA
         type:PostalAddress
      name:Department of Veterans Affairs Medical Center
      address:
         name:VA Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, USA
         type:PostalAddress
      name:University of Washington School of Medicine
      address:
         name:Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:James E. Blevins
      affiliation:
            name:Department of Veterans Affairs Medical Center
            address:
               name:VA Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, USA
               type:PostalAddress
            type:Organization
            name:University of Washington School of Medicine
            address:
               name:Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Jacqueline M. Ho
      affiliation:
            name:Department of Veterans Affairs Medical Center
            address:
               name:VA Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, USA
               type:PostalAddress
            type:Organization
            name:University of Washington School of Medicine
            address:
               name:Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:VA Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, USA
      name:Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, USA
      name:VA Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, USA
      name:Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(626)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.48s.

LINK . SPRINGER . COM {}